Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 7, 2013; 19(5): 654-664
Published online Feb 7, 2013. doi: 10.3748/wjg.v19.i5.654
Published online Feb 7, 2013. doi: 10.3748/wjg.v19.i5.654
In vitromodel/cell culture system | Step of the viral cycle | Benefits and major findings | Drawbacks | |
HBV | Primary hepatocyte cultures | Not easy to handle | ||
PHH | Replication | No need for DMSO and hydrocortisone for PTH system | Cells cannot be propagated in vitro | |
PTH | Addition of growth factors | |||
Hepatic cell lines | ||||
HepG2 | Binding and infection | Specific binding and uptake | No productive infection | |
HepaRG | (HBV and HDV) | Cellular determinants of hepatocyte differentiation and their influence on HBV infection | Addition of DMSO and hydrocortisone | |
HCV | Recombinant E2 glycoprotein: Truncated soluble form of recombinant E2 glycoprotein | Entry process | Identification of two major receptors CD81 and SR-BI | Different behavior from E1 E2 heterodimers |
Interaction with heparan sulfate proteoglycans | Binding to various cell lines different from hepatocytes | |||
VLPs: Self assembly of HCV structural proteins produced in insect or mammalian cells using a recombinant virus | Entry process | E1–E2 heterodimers at virion surface | Difference in glycosylation status | |
Cell attachment | Difficult to prepare | |||
Attractive vaccine candidate | Non replicative | |||
HCVpp: Unmodified HCV envelope glycoproteins assembled onto retroviral or lentiviral core particles | Entry process | Study of infectivity and neutralization | Only the very early steps of viral cycle | |
No association with lipoproteins | ||||
No budding at the ER | ||||
HCVcc: Transfection of one HCV strain sequence (JFH1) from a Japanese patient with fulminant hepatitis, in Huh 7 cell line. | Entire life cycle | Entry process +++ | Restricted to Huh-7 cell line | |
Replication | Restricted to JFH1 non structural proteins sequence | |||
Virus production | ||||
Screening of antiviral molecules |
- Citation: Jeulin H, Velay A, Murray J, Schvoerer E. Clinical impact of hepatitis B and C virus envelope glycoproteins. World J Gastroenterol 2013; 19(5): 654-664
- URL: https://www.wjgnet.com/1007-9327/full/v19/i5/654.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i5.654